To assess the clinical relevance of these findings we employed a patient-derived xenograft model, transplanting CML CD34+ cells into sub-lethally irradiated immunocompromised NRG-W41 mice50 (Fig. 6a). This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.